COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India
JM Aranjani, A Manuel, HI Abdul Razack… - PLoS neglected …, 2021 - journals.plos.org
Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021, has caused
devastating chaos in India. As daily infection rates rise alarmingly, the number of severe …
devastating chaos in India. As daily infection rates rise alarmingly, the number of severe …
Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …
[HTML][HTML] Multicenter case–control study of COVID-19–associated mucormycosis outbreak, India
In support of improving patient care, this activity has been planned and implemented by
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and …
Summary COVID-19-associated pulmonary mucormycosis (CAPM) remains an
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …
Fungal infection in co-infected patients with COVID-19: an overview of case reports/case series and systematic review
SS Seyedjavadi, P Bagheri, MJ Nasiri… - Frontiers in …, 2022 - frontiersin.org
Fungal co-infections are frequent in patients with coronavirus disease 2019 (COVID-19) and
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …
Let's talk about sex characteristics—as a risk factor for invasive fungal diseases
Biological sex, which comprises differences in host sex hormone homeostasis and immune
responses, can have a substantial impact on the epidemiology of infectious diseases …
responses, can have a substantial impact on the epidemiology of infectious diseases …
What is new in pulmonary mucormycosis?
F Danion, A Coste, C Le Hyaric, C Melenotte, F Lamoth… - Journal of Fungi, 2023 - mdpi.com
Mucormycosis is a rare but life-threatening fungal infection due to molds of the order
Mucorales. The incidence has been increasing over recent decades. Worldwide, pulmonary …
Mucorales. The incidence has been increasing over recent decades. Worldwide, pulmonary …
[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
Antifungal effect of nanoparticles against COVID-19 linked black fungus: a perspective on biomedical applications
S Gurunathan, AR Lee, JH Kim - International Journal of Molecular …, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and pathogenic coronavirus that has caused a 'coronavirus disease 2019'(COVID-19) …
and pathogenic coronavirus that has caused a 'coronavirus disease 2019'(COVID-19) …
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India–a multi-centre study
Background An unprecedented rise in the number of COVID-19-associated mucormycosis
(CAM) cases has been reported in India. Myriad hypotheses are proposed for the outbreak …
(CAM) cases has been reported in India. Myriad hypotheses are proposed for the outbreak …